Cancer therapeutic could help treat and prevent brain disorders
Down-regulation of a poly(ADP-ribose) polymerase by a potential anticancer therapeutic reduces cytoplasmic TDP-43 aggregation, which is seen in diseases such as amyotrophic lateral sclerosis.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.